Who Should Bank Their Fat Stem Cells? The Ideal Patient Profile for Adipose Tissue Banking
Adipose tissue banking is most valuable for adults who are healthy enough to have the harvest procedure, motivated by a proactive approach to their long-term health, and in a life stage where preserving high-quality cells now gives them meaningful option value against the ADSC clinical trial and approval pipeline. It is not a service that […]
What Is Save My Fat? The Complete Guide to How the Program Works
Save My Fat is a tissue banking program that allows adults to preserve their own adipose-derived stem cells through a thirty-minute outpatient harvest procedure, processed and cryopreserved by L2 Bio for long-term storage and potential future use in clinical trials, expanded access programs, and FDA-approved therapies as they develop. The program connects patients with trained […]
How to Talk to Your Doctor About Adipose Tissue Banking: A Patient’s Conversation Guide
Most patients who are interested in adipose tissue banking will want to discuss it with their primary care physician, specialist, or functional medicine provider before booking, and many will encounter a physician who is not yet familiar with the banking framework, the regulatory structure, or the current state of the ADSC clinical trial pipeline. This […]
How to Think About the Cost of Adipose Tissue Banking: A Framework for Making the Decision
Adipose tissue banking is a cash-pay health service typically priced between $8,000 and $15,000 depending on the package, provider, and storage terms, which makes it a significant financial decision that deserves a clear-eyed evaluation framework rather than an impulse. The right way to think about banking cost is not as a medical procedure expense but […]
Adipose Tissue Banking and Longevity Medicine: Why Health-Forward Adults Are Banking Their Fat Stem Cells Now
The longevity medicine movement has given health-forward adults a framework for thinking about their biology as something to measure, optimize, and preserve, not just treat when something goes wrong. Adipose tissue banking fits directly into that framework: it is a one-time procedure that preserves your own adipose-derived stem cells at their current biological quality, for […]
Adipose-Derived Stem Cells in Neurological Conditions: What the Research Shows
Neurological conditions, including ALS, stroke recovery, spinal cord injury, Parkinson’s disease, and multiple sclerosis, represent one of the most active areas of mesenchymal stem cell research, driven by the lack of effective standard treatments for most of these conditions and the biological plausibility of MSC neuroprotective and anti-inflammatory mechanisms. The evidence base for adipose-derived stem […]
Adipose-Derived Stem Cells in Aesthetic Medicine: What Plastic Surgeons and Patients Need to Know
Aesthetic medicine is the most commercially mature application area for adipose-derived stem cells, with a published evidence base covering fat grafting enhancement, skin rejuvenation, scar treatment, and wound healing that stretches back over a decade. The biological mechanism is well-characterized: ADSCs secrete growth factors that promote angiogenesis, collagen synthesis, and tissue regeneration, which makes them […]
Adipose-Derived Stem Cells in Autoimmune and Inflammatory Conditions: What the Evidence Shows
The December 2024 FDA approval of Ryoncil for steroid-refractory acute graft-versus-host disease was not an orthopedic milestone. It was an immune milestone, confirming that the FDA will approve mesenchymal stem cell-based therapies for immune and inflammatory conditions when the Phase 3 evidence supports them. Adipose-derived stem cells share the same core immunomodulatory properties that drove […]
Expanded Access Programs for Investigational Drugs: What Physicians and Patients Need to Know
Expanded access, also called compassionate use, is the FDA pathway that allows patients with serious or life-threatening conditions to access investigational drugs, biologics, or medical devices outside of a clinical trial when no comparable alternative therapy is available. The process requires the treating physician to submit a request to the FDA and obtain agreement from […]
MFAT Injections: What They Are, What the Evidence Shows, and How They Relate to Banking
MFAT, micro-fragmented adipose tissue, is a preparation of mechanically processed fat tissue that retains an intact stromal vascular niche, including adipose-derived stem cells, pericytes, and extracellular matrix components, and is injected at the site of injury or disease. Multiple clinical trials have evaluated MFAT injections for orthopedic applications, particularly knee osteoarthritis, with published data demonstrating […]
